18 results
IDSA 2017 CDiff Guidelines - Table 7. Potential Treatment Agents for Treatment of the Primary Clostridium difficile
IDSA 2017 CDiff ... Guidelines - Table ... Clostridium difficile infection ... Episode #Pharmacology ... CDifficile #IDSA2017 #Adjunct
IDSA 2017 CDiff Guidelines - Table 1. Recommendations for the Treatment of Clostridium difficile Infection in Adults

#Management
IDSA 2017 CDiff ... Guidelines - Table ...  1. ... Recommendations for the Treatment ... Clostridium difficile Infection
C.diff - Clostridioides Difficile Infection (CDI) - Diagnosis and Management - GrepMed Handbook

Clinical Presentation + Progression:
Epidemiology: • #1 ... 10 mg/kg IV x 1 ... - Adjunct Tx given ... Guideline: https ... ciab549 #CDI #Cdiff
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
screen within 1 ... 0.5mL IM at 0, 1– ... IDSA #Prevention #Treatment ... #management #opportunistic ... #pharmacology
Guidelines on Management of Clostridioides difficile Infection (CDI) in Adults
 • Non-Severe CDI
 • Severe CDI
Guidelines on Management ... Clostridioides difficile Infection ... Clostridioides #difficile #CDiff ... CDI #management #pharmacology ... #treatment
Immune Reconstitution Inflammatory Syndrome - Overview of IRIS

What Is IRIS?
	• A state of hyperinflammatory response that
previously diagnosed opportunistic ... within the first 1 ... decrease in HIV-1 ... infection Treatment ... meningitis • Guidelines
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
4–6 mL QID or 1– ... for effective treatment ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
mg/kg on days 1– ... Leishmaniasis #Prevention #Treatment ... #management #opportunistic ... #infections #HIVAIDS ... #pharmacology
IDSA Recommendations for Treating Cytomegalovirus Infections in HIV-AIDS
Preventing CMV Disease:
 • CMV end-organ disease is best
Cytomegalovirus Infections ... effective for treatment ... ) for 1–4 doses ... #management #opportunistic ... #pharmacology
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
Regimen: • TMP-SMX 1 ... IDSA #Prevention #Treatment ... #opportunistic ... #infections #HIVAIDS ... #pharmacology